Published in PLoS One on July 29, 2014
Intraoperative molecular imaging can identify lung adenocarcinomas during pulmonary resection. J Thorac Cardiovasc Surg (2015) 1.48
Optimization of the enhanced permeability and retention effect for near-infrared imaging of solid tumors with indocyanine green. Am J Nucl Med Mol Imaging (2015) 0.86
Indocyanine green-loaded nanoparticles for image-guided tumor surgery. Bioconjug Chem (2015) 0.86
Correlating molecular character of NIR imaging agents with tissue-specific uptake. J Med Chem (2015) 0.85
Quantification of tumor fluorescence during intraoperative optical cancer imaging. Sci Rep (2015) 0.81
Intraoperative imaging identifies thymoma margins following neoadjuvant chemotherapy. Oncotarget (2016) 0.80
Intraoperative diagnostics and elimination of residual microtumours with plasmonic nanobubbles. Nat Nanotechnol (2016) 0.80
Diverse Applications of Nanomedicine. ACS Nano (2017) 0.80
Near-infrared operating lamp for intraoperative molecular imaging of a mediastinal tumor. BMC Med Imaging (2016) 0.79
Intraoperative near-infrared fluorescence imaging and spectroscopy identifies residual tumor cells in wounds. J Biomed Opt (2015) 0.79
Intraoperative Near-Infrared Optical Imaging Can Localize Gadolinium-Enhancing Gliomas During Surgery. Neurosurgery (2016) 0.78
Intraoperative molecular imaging to identify lung adenocarcinomas. J Thorac Dis (2016) 0.77
Stromal Targets for Fluorescent-Guided Oncologic Surgery. Front Oncol (2015) 0.77
Image-guided tumor surgery: will there be a role for fluorescent nanoparticles? Wiley Interdiscip Rev Nanomed Nanobiotechnol (2015) 0.77
Intraoperative near-infrared fluorescence imaging targeting folate receptors identifies lung cancer in a large-animal model. Cancer (2016) 0.75
Intraoperative near-infrared imaging of mesothelioma. Transl Lung Cancer Res (2017) 0.75
The hallmarks of cancer. Cell (2000) 113.05
The new lung cancer staging system. Chest (2009) 6.30
Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol (2002) 6.06
Design considerations for tumour-targeted nanoparticles. Nat Nanotechnol (2009) 4.06
Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res (2007) 3.25
The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol (2011) 3.24
Fluorescence-guided surgery with live molecular navigation--a new cutting edge. Nat Rev Cancer (2013) 3.08
Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res (2013) 2.98
Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development (1994) 2.71
Translation of near-infrared fluorescence imaging technologies: emerging clinical applications. Annu Rev Med (2011) 2.60
Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target (2007) 2.50
Near-infrared fluorescence-guided resection of colorectal liver metastases. Cancer (2013) 1.71
IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2. J Immunol (2003) 1.62
Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies. J Nucl Med (2011) 1.62
Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Methods Mol Biol (2010) 1.61
Current trends and emerging future of indocyanine green usage in surgery and oncology: a literature review. Cancer (2011) 1.55
Hand-held spectroscopic device for in vivo and intraoperative tumor detection: contrast enhancement, detection sensitivity, and tissue penetration. Anal Chem (2010) 1.47
Intraoperative multispectral fluorescence imaging for the detection of the sentinel lymph node in cervical cancer: a novel concept. Mol Imaging Biol (2011) 1.41
Nanotechnology applications in surgical oncology. Annu Rev Med (2010) 1.31
Intraoperative near-infrared imaging of surgical wounds after tumor resections can detect residual disease. Clin Cancer Res (2012) 1.30
Assessing margin status. Surg Oncol (1999) 1.27
Translating in vivo diagnostics into clinical reality. Nat Biotechnol (2006) 1.23
Small portable interchangeable imager of fluorescence for fluorescence guided surgery and research. Technol Cancer Res Treat (2014) 1.17
Local and systemic recurrence is the Achilles heel of cancer surgery. Ann Surg Oncol (2011) 1.15
A positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation. Cancer Biol Ther (2012) 1.00
Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models. Cancer Gene Ther (2011) 0.99
Intraoperative near-infrared fluorescence imaging of colorectal metastases targeting integrin α(v)β(3) expression in a syngeneic rat model. Eur J Surg Oncol (2011) 0.97
Vascular endothelial-targeted therapy combined with cytotoxic chemotherapy induces inflammatory intratumoral infiltrates and inhibits tumor relapses after surgery. Neoplasia (2012) 0.96
Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness. J Hematol Oncol (2012) 0.94
Experimental diabetes induces structural, inflammatory and vascular changes of Achilles tendons. PLoS One (2013) 0.88
Intraoperative T staging in radical retropubic prostatectomy: is it reliable? Urology (2001) 0.85
Characterization of surgical models of postoperative tumor recurrence for preclinical adjuvant therapy assessment. Am J Transl Res (2012) 0.83
Nanotechnology in thoracic surgery. Ann Thorac Surg (2010) 0.79